MedTrace Logo

Chemotherapy-Related Toxicities In Ovarian Cancer Patients

NCT00508378 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 288

Last updated 2020-11-13

No results posted yet for this study

Summary

Primary Objectives:

1. To assess the preferences of women with ovarian cancer, their clinical caregivers, familial caregivers, and a control group for toxicities associated with chemotherapy.

* To compare preferences of women with ovarian cancer to preferences of their clinical caregivers.
* To compare preferences of women with ovarian cancer to preferences of their familial caregivers.
* To compare preferences of women with ovarian cancer to preferences of a women in the control group.
2. To prospectively collect quality of life data from women with ovarian cancer.
3. To prospectively collect symptom assessment data from women with ovarian cancer.

Conditions

Interventions

BEHAVIORAL

Interview

Interview regarding side-effects of chemotherapy, 30-45 minutes.

BEHAVIORAL

Questionnaire

Quality of life survey and symptom assessment questionnaire, 15 minutes.

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Diane C. Bodurka, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-01-31
Primary Completion
2020-11-03
Completion
2020-11-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00508378 on ClinicalTrials.gov